The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterised by the progressive loss of motor neurons, leading to muscle weakness, paralysis and, ultimately, ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurological condition that eventually results in the loss of the ability to walk, talk, and swallow. In most cases, the cause of ALS is unknown.
DelveInsight's, “Amyotrophic Lateral Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline ...
Human brain, illustration. A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of ...
Ancient viral DNA in the human genome linked to multiple sclerosis and amyotrophic lateral sclerosis
New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous system. New research from King ...
Over the last decade, researchers at the University of Michigan have continued to find that exposure to environmental toxins—from pesticides used in agriculture to volatile organic compounds in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback